Chemoinformaics analysis of Arabinosyl-Alpha-D-Galactosyl-D-Glucose
| Molecular Weight | 474.412 | nRot | 8 |
| Heavy Atom Molecular Weight | 444.172 | nRig | 13 |
| Exact Molecular Weight | 474.158 | nRing | 2 |
| Solubility: LogS | -0.479 | nHRing | 2 |
| Solubility: LogP | -3.062 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 62 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 32 | No. of Aromatic Carbocycles | 0 |
| nHetero | 15 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 30 | No. of Saturated Hetero Cycles | 2 |
| No. of Carbon atom | 17 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 15 | No. of Arom Bond | 0 |
| nHA | 15 | APOL | 60.4238 |
| nHD | 12 | BPOL | 34.4362 |
| QED | 0.156 |
| Synth | 5.272 |
| Natural Product Likeliness | 1.847 |
| NR-PPAR-gamma | 0.001 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.988 |
| HIA | 0.989 |
| CACO-2 | -6.288 |
| MDCK | 0.000270505 |
| BBB | 0.294 |
| PPB | 0.180991 |
| VDSS | 0.249 |
| FU | 0.580396 |
| CYP1A2-inh | 0.006 |
| CYP1A2-sub | 0.003 |
| CYP2c19-inh | 0.006 |
| CYP2c19-sub | 0.042 |
| CYP2c9-inh | 0 |
| CYP2c9-sub | 0.039 |
| CYP2d6-inh | 0 |
| CYP2d6-sub | 0.056 |
| CYP3a4-inh | 0.002 |
| CYP3a4-sub | 0 |
| CL | 0.847 |
| T12 | 0.788 |
| hERG | 0.289 |
| Ames | 0.06 |
| ROA | 0.006 |
| SkinSen | 0.034 |
| Carcinogencity | 0.003 |
| EI | 0.013 |
| Respiratory | 0.019 |
| NR-Aromatase | 0.031 |
| Antiviral | Yes |
| Prediction | 0.708954 |